The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 337:1623-1625 November 27, 1997 Number 22
NextNext

Sickle Cell Disease and the Endothelium

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
The enduring puzzle of sickle cell anemia is how a single deviant base in DNA, which changes a single amino acid in a single protein within a single type of cell, causes a disease with such variable clinical manifestations. Clearly, additional factors — situational and genetic — influence the course of this genetically simple yet clinically complex disorder. Genetic variables that influence the severity of sickle cell disease include levels of other hemoglobins, such as hemoglobin F or hemoglobin C. Other factors, such as responses to episodes of infectious disease, are strongly suspected to predispose patients to sickle crises, but . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.